TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome
Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.